Allison Gaudy

6PUBLICATIONS
21CO-AUTHORS
Biomolecular modelling and designMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Psychological methodology, design and analysisRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 08, 2025
Application of Physiologically Based Pharmacokinetic Modeling to Inform Dose Selection of Mezigdomide in a Phase I Drug-Drug Interaction Study.

Joseph Burnett, Caroline Sychterz, Jessica Katz

|Jul 04, 2024
Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology.

Mohamed Elmeliegy, Joseph Chen, Aruna Dontabhaktuni

|Jun 28, 2024
Informing the Recommended Phase III Dose of Alnuctamab, a CD3 × BCMA T-Cell Engager, Using Population Pharmacokinetics and Exposure-Response Analysis.

Brian Kiesel, Mayu Osawa, Madhan Masilamani

|Jul 08, 2023
Population Pharmacokinetics of Oral Azacitidine, and Exposure-Response Analysis in Acute Myeloid Leukemia.

Allison Gaudy, Eric Laille, Rochelle Bailey

|Jul 23, 2021
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.

Charlotte M Niemeyer, Christian Flotho, Daniel B Lipka

|Sep 23, 2020
Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects.

Allison Gaudy, Christian Atsriku, Ying Ye

Pageof 1

Frequent Collaborators

1 joint publications

Charlotte M Niemeyer

1 joint publications

Daniel B Lipka

1 joint publications

Claudia Rössig

1 joint publications

André Baruchel